Table 5.
Association between anthropometric measurements and fecal markers of EE at 9-month follow-up (N = 205)
| Outcome | % | Calprotectin OR (95% CI)* | EE score OR (95% CI)* | ||
|---|---|---|---|---|---|
| Age adjusted (Q1 vs. Q4) | Fully adjusted† (Q1 vs. Q4) | Age adjusted (Q1 vs. Q4) | Fully adjusted† (Q1 vs. Q4) | ||
| Proportion WAZ < −2 | 24 | 1.21 (0.43, 3.40) | 1.27 (0.45, 3.59) | 3.74 (1.38, 10.15)‡ | 3.73 (1.38, 10.12)‡ |
| Proportion HAZ < −2 | 34 | 2.02 (0.77, 5.27) | 2.25 (0.83, 6.10) | 1.30 (0.54, 3.13) | 1.32 (0.54, 3.22) |
| Proportion WHZ < −2 | 7 | 2.12 (0.20, 22.77) | 2.56 (0.24, 27.81) | 3.13 (0.57, 17.25) | 3.18 (0.57, 17.73) |
CI = confidence interval; EE = environmental enteropathy; HAZ = length/height-for-age z-score; OR = odds ratio; WAZ = weight-for-age z-score; WHZ = weight-for-length/height z-score.
*
OR compares the first to the fourth quartile.
†
Fully adjusted models adjust for age, age squared, caregiver educational level, and family size.
‡
P value < 0.05.